May 16, 2007
Fresenius Expects Continued Growth in Sales and Earnings – Annual General Meeting Approves Higher Dividend
Following the company's very strong 2006 financial results, Fresenius expects to significantly expand its sales and earnings in 2007. At the company's Annual General Meeting in Frankfurt, Germany, Dr. Ulf M. Schneider, Chairman of the Management Board, said that "We have had an excellent start into the fiscal year 2007 and confirm our guidance for the full year." According to the company's outlook released in February, Fresenius expects Group sales to increase on a currency-adjusted basis by 8 to 10% in 2007 while net income is expected to grow by 20 to 25%.
Referring to the company's mid-term goals, Dr. Schneider stated: "We intend to continue our steady growth as we look towards the year 2010. The Management Board has set a mid-term target we call 15/15. We are targeting revenues of €15 billion and we expect to achieve an EBIT margin of 15% by the year 2010. We plan to achieve this target through sales and earnings growth in all business segments. In addition, we will be looking to strengthen our business segments through small and mid-sized acquisitions."
During the Annual General Meeting Fresenius shareholders unanimously approved a 15 percent increase in dividends, the 14th consecutive increase. Holders of ordinary shares will receive €0.57 per share (2005: €0.49, after adjusted for the share split) and holders of preference shares will receive €0.58 (2005, €0.50, after adjusted for the share split). A total of €88.8 million (2005: €75.8 million) will be distributed as dividends.
90.88 percent of the ordinary share capital and 8.73 percent of the preference share capital was represented at the Annual General Meeting. Shareholders approved the actions of the Management and Supervisory Boards with an overwhelming majority (99.99 percent).
# # #
Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and the ambulatory medical care of patients. In 2006 group sales were about € 10.8 billion. On December 31, 2006 the Fresenius Group had 104,872 employees worldwide.